Pediatrics

Projects

Projects per year 2006 2009 2014 2016 2017 2018 2020 2021 2022 2023 2024 2029

• 38 Active
• 86 Completed

Projects per year

Search results

• Completed

  EL II: Functional Portraits of tRNA-derived Small Non-coding RNAs

  Bao, X. (PI)

  National Institute of Allergy and Infectious Diseases ( Award #5R21AI11377102)

  6/15/15 → 5/31/17

  Project: Research project

• Respiratory Syncytial Virus Utilizes a tRNA 5¿-end Fragment to Suppress Host antiviral Response

  Bao, X. (PI)

  American Thoracic Society ( Award # )

  11/30/14 → 11/29/16

  Project: Research project

• EL II: Engineering of a Novel CDN Nanoparticle Platform

  Bourne, N. (PI)

  Molecular Express, Inc ( Award #1R43AI11213201A1)

  9/1/14 → 9/30/15

  Project: Research project

• Enviromental estrogens induced signals in immune cells that promote the development of asthma

  Midoro-Horiuti, T. (PI)

  American Lung Association - New York ( Award #AI310304)

  9/1/14 → 8/31/16

  Project: Research project

• EL II: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Rings

  Pyles, R. (PI)

  Oak Crest Institute of Science ( Award #5U19AI11304805)

  8/11/14 → 7/31/19

  Project: Research project

• V160-001-002: A Phase I Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  6/27/14 → 6/26/18

  Project: Research project

• A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  4/30/14 → 5/1/16

  Project: Research project

• Antibiotic Safety in Infants with Complicated Intra-Abdominal Infections

  Shattuck, K. (PI)

  DUKE UNIVERSITY

  3/27/14 → 9/23/17

  Project: Research project

• V503-010-0007: A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, administered in Preadolescents and Adolescents (9 to 14 yea

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  2/7/14 → 2/6/19

  Project: Research project

• A 48-52 Month Blinded-Outcomes Follow up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-205

  Shattuck, K. (PI)

  Quintiles, Inc.

  12/6/13 → 12/5/19

  Project: Research project

• CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection

  Aigbivbalu, L. (PI)

  Duke University ( Award #HHSO100201300009C)

  12/5/13 → 5/23/15

  Project: Research project

• ELII: Antiviral Innate Pathways and Superoxide Dismutase in RSV Bronchiolitis

  Garofalo, R. P. (PI)

  National Institute of Allergy and Infectious Diseases ( Award #5R21AI10908802)

  12/4/13 → 11/30/16

  Project: Research project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections

  Aigbivbalu, L. (PI)

  Duke University ( Award # )

  11/13/13 → 11/12/15

  Project: Research project

• A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination with Phototherapy in Neonates

  Shattuck, K. (PI)

  Quintiles, Inc.

  9/26/13 → 9/25/17

  Project: Research project

• Pharmacokinetics of Antistaphylococcal Antibiotics in Infants; HHSN- 2752010000031

  Shattuck, K. (PI)

  DUKE UNIVERSITY

  2/23/13 → 8/26/15

  Project: Research project

• Protocol No.: V503-003-00-0255: "A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillornavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year Old Men and 16- to 26-Year Old Women"

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  1/3/13 → 1/2/15

  Project: Research project

• Phase 1b, Partial-Blind, Parallel Group, Randomized Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine (DENVax) Administered Intradermally Using Needle or a Needle-Free PharmaJet Injector in Healthy Adults

  Rupp, R. (PI)

  Takeda Vaccines, Inc ( Award #HHSN272201000034C)

  12/31/12 → 12/6/15

  Project: Research project

• Guinea Pig Study for Therapeutic Vaccine

  Bourne, N. (PI)

  Vical, Inc ( Award # )

  12/1/12 → 12/1/13

  Project: Research project

• Human Metapneumorivus M2-2 Protein Promotes Viral Evasion from Host Innate Immunity

  Bao, X. (PI)

  American Lung Association - New York ( Award #RG232529N)

  7/1/12 → 6/30/15

  Project: Research project

• Protocol No.: V221-027; A Phase III Double-Blind, Randomized, Multicenter, Contgrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made with Alternative Manufacturing Process (AMP)

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  6/21/12 → 6/20/14

  Project: Research project

• Protocol No.: V59P23; "A Phase 3b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants"

  Rupp, R. (PI)

  Novartis Vaccines and Diagnostics, Inc ( Award # )

  4/27/12 → 4/26/14

  Project: Research project

• Protocol: V114-002-008, "A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of a Pneumococcal Conjugate Vaccine (V114) Compared to Pneumococcal Polysaccharide Vaccine (PNEUMOVAX 23) and Prevnar 13 (Pneumococcal 13-Valent

  Rupp, R. (PI)

  Merck Sharp and Cohme Corporation ( Award # )

  3/1/12 → 6/14/19

  Project: Research project

• Protocol Number: INV-DEN-104; A Randomized, Phase 1b Study to Investigate the Safety and Immunogenicty of Various Schedules of Tetravalent Chimeric Dengue Vaccine in Healthy Adult Volunteers Between the Ages of 18-45 Years

  Rupp, R. (PI)

  Takeda Vaccines, Inc ( Award # )

  12/20/11 → 9/1/15

  Project: Research project

• Protocol B1971011: A Phase 2, Randomized, Single-Blind Trial, To Asess the Safety, Tolerability and Immunogenicity of Gardasil Vaccine and rLP2086 Vaccine When Administered Concomitantly in Healthy Subjects Aged >/= 11 to </=17 Years

  Rupp, R. (PI)

  Pfizer, Inc ( Award # )

  8/1/11 → 1/1/15

  Project: Research project

• The Role of Altered B7-homologue expression by ISEMFs in IBD

  Reyes, V. E. (PI)

  Crohn's and Colitis Foundation of America ( Award #2840)

  7/1/10 → 6/30/14

  Project: Research project

• Innate Immune Response to Human Metapneumovirus Infection

  Casola, A. (PI)

  National Institute of Allergy and Infectious Diseases ( Award #5R01AI07924605)

  6/1/10 → 5/31/17

  Project: Research project

• Early Childhood Intervention (84.027)

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/31/20

  Project: Research project

• Early Childhood Intervention (93.558)

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/31/20

  Project: Research project

• Early Childhood Intervention (84.393)

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/31/20

  Project: Research project

• Early Childhood Intervention - ARRA

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/31/20

  Project: Research project

• Early Childhood Intervention (Non ARRA)

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/31/20

  Project: Research project

• Early Childhood Intervention (84.181)

  Richardson, J. (PI)

  Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)

  9/1/09 → 8/30/20

  Project: Research project

• Herpes Simplex Immunotherapeutic Vaccine

  Bourne, N. (PI)

  Vical, Inc ( Award #5R42AI06501503)

  4/1/09 → 3/31/12

  Project: Research project

• Protocol No. V59P13E1: A Phase 3, Open-Label,Multi-Center Study to Evaluate the Persistence of Novartis MenACWY Antibody Response in Adolescents who Have Previously received either Novartis MenACWY Conjugate Vaccine or Menactra

  Rupp, R. (PI)

  Novartis Vaccines and Diagnostics, Inc ( Award #V59P13E1)

  2/2/09 → 2/1/15

  Project: Research project

• Novartis V59P13: A Phase III, Randomized, Ovserver-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of Novartis Meningococcal ACWY Conjugate Vaccine when One Dose is Administered to Healthy Adolescents 11-18 Years of Age and t

  Rupp, R. (PI)

  Novartis Pharmaceuticals Corporation ( Award # )

  2/10/07 → 3/31/15

  Project: Research project

• Testing 5 Compounds in the 1A Replicon System

  Bourne, N. (PI)

  Anadys Pharmaceuticals ( Award # )

  6/1/06 → 2/26/12

  Project: Research project